Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jukka Westermarck

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
The FEBS Journal|July 29, 2018
Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes backJukka Westermarck
Molecular Oncology|February 28, 2023
Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?Jukka Westermarck
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2010
Regulation of transcription factor function by targeted protein degradation: an overview focusing on p53, c-Myc, and c-JunJukka Westermarck
Biochemical Society Transactions|December 4, 2016
Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1Amanpreet Kaur, Jukka Westermarck
The International Journal of Biochemistry & Cell Biology|January 23, 2018
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancerOtto Kauko, Jukka Westermarck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cellsAnni Laine, Jukka Westermarck
Trends in Cancer|October 4, 2023
CIP2A coordinates phosphosignaling, mitosis, and the DNA damage responseSrikar Nagelli, Jukka Westermarck
Cell|May 4, 2020
Piecing Together a Broken Tumor Suppressor Phosphatase for Cancer TherapyJukka Westermarck, Benjamin G Neel
Cancer Cell|July 15, 2020
Good Guy in Bad Company: How STRNs Convert PP2A into an OncoproteinKari J Kurppa, Jukka Westermarck
Trends in Molecular Medicine|March 11, 2008
Multiple pathways regulated by the tumor suppressor PP2A in transformationJukka Westermarck, William C Hahn
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
The FEBS Journal|July 29, 2018
Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes backJukka Westermarck
Molecular Oncology|February 28, 2023
Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?Jukka Westermarck
Methods in Molecular Biology (Clifton, N.J.)|August 10, 2010
Regulation of transcription factor function by targeted protein degradation: an overview focusing on p53, c-Myc, and c-JunJukka Westermarck
Biochemical Society Transactions|December 4, 2016
Regulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1Amanpreet Kaur, Jukka Westermarck
The International Journal of Biochemistry & Cell Biology|January 23, 2018
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancerOtto Kauko, Jukka Westermarck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cellsAnni Laine, Jukka Westermarck
Trends in Cancer|October 4, 2023
CIP2A coordinates phosphosignaling, mitosis, and the DNA damage responseSrikar Nagelli, Jukka Westermarck
Cell|May 4, 2020
Piecing Together a Broken Tumor Suppressor Phosphatase for Cancer TherapyJukka Westermarck, Benjamin G Neel
Cancer Cell|July 15, 2020
Good Guy in Bad Company: How STRNs Convert PP2A into an OncoproteinKari J Kurppa, Jukka Westermarck
Trends in Molecular Medicine|March 11, 2008
Multiple pathways regulated by the tumor suppressor PP2A in transformationJukka Westermarck, William C Hahn
Pageof 10